arrow
M

Min Jun

University of New South Wales
H指数:46
被引数:9,967

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: insights from the CREDENCE trial

卡格列净在CKD患者中不同联合用药负担下的疗效和安全性具有一致性:来自CREDENCE试验的见解

2026-09-040
OAAI
Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

住院是导致2型糖尿病患者停用钠-葡萄糖协同转运蛋白2抑制剂的一个强风险因素

2026-08-280
OAAI
Caring for Australians and New Zealanders with kidney Impairment guidelines commentary on the Kidney Disease: Improving Global Outcomes clinical practice guideline for management of diabetes and chronic kidney disease

关爱澳大利亚和新西兰肾脏功能受损患者指南:对《全球肾脏病结局改善组织糖尿病和慢性肾脏病管理临床实践指南》的评论

2026-02-010
OAAI
Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice dataset

澳大利亚初级保健中慢性肾脏疾病护理模式的性别差异: 国家全科医学数据集的回顾性队列研究

2026-01-210
PRE
The Association between Low-Grade Proteinuria and Adverse Kidney Outcomes in IgA Nephropathy A Systematic Review and Meta-Analysis

低级别蛋白尿与IgA肾病不良肾脏结局之间的关联:一项系统评价和荟萃分析

2025-12-010
PRE
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

2型糖尿病伴与不伴慢性肾脏病患者SGLT2抑制剂和GLP1受体激动剂处方的应用现状:一项基于澳大利亚初级保健数据集的分析

2025-07-160
OAAI
Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset

评估澳大利亚初级保健中慢性肾病护理模式:一项基于全国综合诊所数据集的回顾性队列研究

2025-04-010
OAAI
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial

卡格列净在老年人中的心血管,肾脏和安全性结果: 来自CANVAS计划和cre登斯试验的联合分析

2025-01-090
PRE
Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data

评估慢性肾脏病患者SGLT2抑制剂摄取改善对人群水平的影响: 一项使用常规收集的澳大利亚初级保健数据的横断面观察性研究

2024-02-013
OAAI